Month: February 2024

Equinor (OSE: EQNR, NYSE: EQNR) will on 8 February 2024 commence the first tranche of up to USD 1.2 billion of the share buy-back programme for 2024, as announced at the Capital Market Update 7 February 2024. In this first tranche of the share buy-back programme for 2024, shares for up to USD 396 million will be purchased in the market, implying a total first tranche of up to USD 1.2 billion including shares to be redeemed from the Norwegian State. The tranche will end no later than 5 April 2024. Equinor announces a two-year share buy-back programme of total USD 10-12 billion for 2024-2025, with up to USD 6 billion for 2024, including shares to be redeemed from the Norwegian State. The share buy-back programme will be subject to market outlook and balance sheet strength and be structured into tranches where Equinor will buy back shares...

Key information relating to the proposed cash dividends to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for fourth quarter 2023. Ordinary cash dividend amount: 0.35 Extraordinary cash dividend amount: 0.35 Announced currency: USD Last day including rights: 14 May 2024 Ex-date: 15 May 2024 Record date: 16 May 2024 Payment date: 28 May 2024 Date of approval: the proposed cash dividends are subject to approval by the annual general meeting of Equinor ASA on 14 May 2024. Other information: The cash dividends per share in NOK will be communicated 24 May 2024. This information is published in accordance with the requirements of the Continuing Obligations and is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act.

EMERYVILLE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, announced today that it priced an upsized underwritten public offering of 6,586,015 shares of its common stock at a public offering price of $29.50 per share and, in lieu of shares of common stock, to certain investors, pre-funded warrants to purchase 3,583,476 shares of common stock at a public offering price of $29.4999, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. In addition, 4D Molecular Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,525,423...

SINGAPORE, Feb. 06, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) and the Association of Corporate Counsel Singapore (“ACC Singapore”) today announced findings from A New Era of Legal Advisor: 2024 In-House Counsel – Perspectives from Asia report, which uncovered substantial changes in how global legal departments are strategizing around and preparing for their biggest risks, including artificial intelligence (“AI”). Most notably, 95% of in-house legal counsel in Asia surveyed are using generative AI in some capacity for legal tasks, such as data processing (54%), risk identification and assessment (51%), regulatory change management (48%) and sanctions screening (43%). However, 65% of respondents said their companies have not provided sufficient guidance for the use of generative AI, and 45% said they do not have specific...

GUADALAJARA, Mexico, Feb. 06, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for January 2024, compared with January 2023. For January 2024, the total number of terminal passengers at GAP’s 12 Mexican airports decreased by 1.6%, compared to January 2023. Puerto Vallarta and Guadalajara presented an increase in passenger traffic of 1.9% and 1.0%, respectively, while Tijuana and Los Cabos presented a decrease of 7.1% and 3.8%, respectively, compared to January 2023. On the other hand, Montego Bay presented an increase in passenger traffic of 9.6% compared to January 2023.             Domestic Terminal Passengers (in thousands):          Airport Jan-23 Jan-24 % Change    Guadalajara 991.1 911.7 (8.0%)    Tijuana* 713.6 678.8 (4.9%)    Puerto...

Business HighlightsFourth quarter sales increased 17% Q/Q and increased 1% Y/YSSD controller sales: 4Q increased 15% to 20% Q/Q and increased 0% to 5% Y/Y eMMC+UFS controller sales: 4Q increased 25% to 30% Q/Q and increased 20% to 25% Y/Y SSD solutions sales: 4Q decreased 5% to 10% Q/Q and decreased 45% to 50% Y/YAnnounced annual cash dividend of $2.00 per ADSFinancial Highlights  4Q 2023 GAAP 4Q 2023 Non-GAAP•   Net sales $202.4 million (+17% Q/Q, +1% Y/Y) $202.4 million (+17% Q/Q, +1% Y/Y)•   Gross margin 43.7% 44.1%•   Operating margin 8.7% 13.8%•   Earnings per diluted ADS $0.63 $0.93  Full Year 2023 GAAP Full Year 2023 Non-GAAP•   Net sales $639.1 million (-32% Y/Y) $639.1 million (-32% Y/Y)•   Gross margin 42.3% 43.0%•   Operating margin 6.2% 11.9%•   Earnings per diluted ADS $1.58 $2.27TAIPEI,...